Evidence map›Paper›PMID 35808407›Full record

ArticleSensors (Basel, Switzerland)2022

HoloLens 1 vs. HoloLens 2: Improvements in the New Model for Orthopedic Oncological Interventions.

Alicia Pose-Díez-de-la-Lastra, Rafael Moreta-Martinez, Mónica García-Sevilla, David García-Mato, José Antonio Calvo-Haro, Lydia Mediavilla-Santos, Rubén Pérez-Mañanes, Felix von Haxthausen, Javier Pascau

Open access · goldAbstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. An Augmented Reality System with Advanced User Interfaces for Image-Guided Intervention Applications.Proceedings of SPIE--the International Society for Optical Engineering · 2023
    Article
  14. Article
  15. Article
  16. HoloLensTherapeutic advances in urology
    Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Alicia Pose-Díez-de-la-LastraDepartamento de Bioingeniería e Ingeniería Aeroespacial, Universidad Carlos III de Madrid, 28911 Leganés, Spain.ORCID 0000-0003-1802-2884
Rafael Moreta-MartinezDepartamento de Bioingeniería e Ingeniería Aeroespacial, Universidad Carlos III de Madrid, 28911 Leganés, Spain.ORCID 0000-0002-3973-5253
Mónica García-SevillaDepartamento de Bioingeniería e Ingeniería Aeroespacial, Universidad Carlos III de Madrid, 28911 Leganés, Spain.ORCID 0000-0002-7330-9194
David García-MatoDepartamento de Bioingeniería e Ingeniería Aeroespacial, Universidad Carlos III de Madrid, 28911 Leganés, Spain.ORCID 0000-0001-5390-5768
José Antonio Calvo-HaroInstituto de Investigación Sanitaria Gregorio Marañón, 28007 Madrid, Spain.
Lydia Mediavilla-SantosInstituto de Investigación Sanitaria Gregorio Marañón, 28007 Madrid, Spain.ORCID 0000-0003-4733-1117
Rubén Pérez-MañanesInstituto de Investigación Sanitaria Gregorio Marañón, 28007 Madrid, Spain.
Felix von HaxthausenInstitute for Robotics and Cognitive Systems, University of Lübeck, 23562 Lübeck, Germany.ORCID 0000-0001-9679-5693
Javier PascauDepartamento de Bioingeniería e Ingeniería Aeroespacial, Universidad Carlos III de Madrid, 28911 Leganés, Spain.ORCID 0000-0003-1484-731X
Hospital General Universitario Gregorio Marañón · ESUniversidad Complutense de Madrid · ESUniversity of Lübeck · DE

Funding

Asociación Española Contra el Cáncer PerPlanRTComunidad de Madrid IND2018/TIC-9753Instituto de Salud Carlos III AC20/00102-3Instituto de Salud Carlos III PI18/01625
6 · The paper itself

Abstract

This work analyzed the use of Microsoft HoloLens 2 in orthopedic oncological surgeries and compares it to its predecessor (Microsoft HoloLens 1). Specifically, we developed two equivalent applications, one for each device, and evaluated the augmented reality (AR) projection accuracy in an experimental scenario using phantoms based on two patients. We achieved automatic registration between virtual and real worlds using patient-specific surgical guides on each phantom. They contained a small adaptor for a 3D-printed AR marker, the characteristic patterns of which were easily recognized using both Microsoft HoloLens devices. The newest model improved the AR projection accuracy by almost 25%, and both of them yielded an RMSE below 3 mm. After ascertaining the enhancement of the second model in this aspect, we went a step further with Microsoft HoloLens 2 and tested it during the surgical intervention of one of the patients. During this experience, we collected the surgeons' feedback in terms of comfortability, usability, and ergonomics. Our goal was to estimate whether the improved technical features of the newest model facilitate its implementation in actual surgical scenarios. All of the results point to Microsoft HoloLens 2 being better in all the aspects affecting surgical interventions and support its use in future experiences.

Indexed as

Augmented RealityOrthopedic ProceduresSurgery, Computer-AssistedErgonomicsHumansPhantoms, ImagingSoftware3D printingaugmented realitycomputer-assisted interventionsMicrosoft HoloLens 1Microsoft HoloLens 2orthopedic oncology

Identifiers

PMID35808407
PMCPMC9269857
OpenAlexW4283719739

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.